Вы находитесь на странице: 1из 1

».3swammx..u.

mznnuTECHNOLOGICAL
vnmmsrrv
mm ti Post
Baccalaureate
SECOND
YEARnunExAMINA'0Nl
October/November - 2011 i T
(LINICAL PHARMACOKINETICS AND
PHARMACOTHERAPEUTIC
§Y§VK\;
3lkMIi's

nnuc
MONITORING
Max.MIrlm70
Answerany live questions
All question:manyequalmarks

*1

1" llriellyexplain
Clinical
phannacokinetics? [14] T

[N]
llcmdoyoudetermine
thedose
anddosing
intervals
ofadrug?
llkischcphamiacokinelic
druginteractions?
[14
j-J
tlxplainhow therapeutic
drugmonitoringwill affectindividualization
of din
dosage
nzgimcn?
M L .. A [14]..

l.\csc.ribe
the
therapeutic
drug
monitoring
ofdrugs
used
incardiovas
dint?
T [14V5
Explain
Pharmacokinetic
considerations
Dosage
adjustment
inRenal
andll
Distsasc? V 7 M

Explaintheanalysis
of population
pharmacokinetic
data?

Explain
theroleof cytochrome in genéi.
P-450isocnzymes
drug
metabolism? _ T

Вам также может понравиться